TY  - GEN
AU  - Ascaso-Del-Rio, Ana
AU  - García-Pérez, Javier
AU  - Perez-Olmeda, Mayte
AU  - Arana-Arri, Eunate
AU  - Vergara, Itziar
AU  - Pérez-Ingidua, Carla
AU  - Bermejo, Mercedes
AU  - Castillo de la Osa, María
AU  - Imaz-Ayo, Natale
AU  - Riaño Fernández, Ioana
AU  - Astasio González, Oliver
AU  - Díez-Fuertes, Francisco
AU  - Meijide, Susana
AU  - Arrizabalaga, Julio
AU  - Hernandez, Lourdes
AU  - de la Torre-Tarazona, Humberto Erick
AU  - Mariano Lázaro, Alberto
AU  - Vargas-Castrillón, Emilio
AU  - Alcamí, José
AU  - Portolés, Antonio
AU  - RescueVac study Group
PY  - 2022
DO  - 10.1016/j.eclinm.2022.101542
UR  - http://hdl.handle.net/20.500.12105/15979
AB  - Background: There is no evidence to date on immunogenic response among individuals who participated in clinical trials of COVID-19 experimental vaccines redirected to standard national vaccination regimens. Methods: This multicentre, prospective...
LA  - eng
PB  - Elsevier
KW  - COVID-19 vaccines
KW  - mRNA vaccines
KW  - Heterologous vaccination
KW  - BNT162b2
KW  - CVnCoV
KW  - Fourth dose
KW  - Neutralizing antibodies
KW  - Boost doses of vaccines
KW  - Omicron
KW  - Experimental vaccines
KW  - Antibodies
KW  - Immune Response
TI  - Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study
TY  - research article
ER  -